neostigmine has been researched along with Myelopathy in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BYLINKINA, EM | 1 |
| Guttmann, L | 1 |
| Walsh, JJ | 1 |
2 other studies available for neostigmine and Myelopathy
| Article | Year |
|---|---|
[Results of application of proserine in brucellous myelitis].
Topics: Brucellosis; Humans; Myelitis; Neostigmine; Spinal Cord Diseases | 1952 |
Prostigmin assessment test of fertility in spinal man.
Topics: Adolescent; Adult; Blood Pressure; Cauda Equina; Cell Count; Ejaculation; Erectile Dysfunction; Fert | 1971 |